Local production of FABP4 in epicardial/perivascular fat and macrophages is mechanistically linked to coronary atherosclerosis.
Answers are grounded in this paper and cite their sources.
Local FABP4 inhibition merits preclinical testing; animal data leave open human coronary atherosclerosis relevance.
FABP4 locally produced by epicardial/perivascular fat and macrophages in vascular plaques contributes to the development of coronary atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Furuhashi et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: